Works by Farolfi, Alberto
Results: 39
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 528, doi. 10.3390/biomedicines13020528
- By:
- Publication type:
- Article
Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- Prostate, 2019, v. 79, n. 11, p. 1211, doi. 10.1002/pros.23804
- By:
- Publication type:
- Article
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland.
- Published in:
- Journal of Cancer Survivorship, 2023, v. 17, n. 6, p. 1847, doi. 10.1007/s11764-022-01222-y
- By:
- Publication type:
- Article
Progress with palbociclib in breast cancer: latest evidence and clinical considerations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 83, doi. 10.1177/1758834016677961
- By:
- Publication type:
- Article
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 538, doi. 10.1002/1878-0261.13120
- By:
- Publication type:
- Article
The impact of radiotherapy, trastuzumab and hormonal therapy on cardiac fibrosis. More is worse?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00137
- By:
- Publication type:
- Article
Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact.
- Published in:
- Oncology, 2013, v. 84, n. 3, p. 150, doi. 10.1159/000345795
- By:
- Publication type:
- Article
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1221096
- By:
- Publication type:
- Article
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1221096
- By:
- Publication type:
- Article
The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA--mutated endometrial cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1088962
- By:
- Publication type:
- Article
Psychosocial Issues in Long-Term Survivors of Testicular Cancer.
- Published in:
- Frontiers in Endocrinology, 2019, p. N.PAG, doi. 10.3389/fendo.2019.00113
- By:
- Publication type:
- Article
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study.
- Published in:
- Journal of Ovarian Research, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13048-022-00970-w
- By:
- Publication type:
- Article
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-792
- By:
- Publication type:
- Article
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Hydroxychloroquine as Prophylaxis for COVID-19: A Review.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.605185
- By:
- Publication type:
- Article
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15789, doi. 10.3390/ijms232415789
- By:
- Publication type:
- Article
Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2569, doi. 10.3390/ijms20102569
- By:
- Publication type:
- Article
Immunotherapy for Prostate Cancer: Where We Are Headed.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 12, p. 2627, doi. 10.3390/ijms18122627
- By:
- Publication type:
- Article
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?
- Published in:
- 2014
- By:
- Publication type:
- journal article
Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33774-4
- By:
- Publication type:
- Article
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 17, p. 2091, doi. 10.1080/14656566.2020.1803281
- By:
- Publication type:
- Article
Sorafenib for the treatment of breast cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 6, p. 621, doi. 10.1080/14656566.2017.1309024
- By:
- Publication type:
- Article
: targeting the cell cycle machinery in breast cancer.
- Published in:
- Expert Opinion on Pharmacotherapy, 2014, v. 15, n. 3, p. 407, doi. 10.1517/14656566.2014.870555
- By:
- Publication type:
- Article
Taxanes as a Risk Factor for Acute Adverse Reactions to Iodinated Contrast Media in Cancer Patients.
- Published in:
- Oncologist, 2014, v. 19, n. 8, p. 823, doi. 10.1634/theoncologist.2013-0470
- By:
- Publication type:
- Article
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.859510
- By:
- Publication type:
- Article
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.716467
- By:
- Publication type:
- Article
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092219
- By:
- Publication type:
- Article
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 840, doi. 10.3390/cancers13040840
- By:
- Publication type:
- Article
Plasma Androgen Receptor in Prostate Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1719, doi. 10.3390/cancers11111719
- By:
- Publication type:
- Article
Treatment Strategies for Advanced Endometrial Cancer According to Molecular Classification.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 21, p. 11448, doi. 10.3390/ijms252111448
- By:
- Publication type:
- Article
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75316-x
- By:
- Publication type:
- Article
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.565857
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01486
- By:
- Publication type:
- Article
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 159, n. 1, p. 79, doi. 10.1007/s10549-016-3923-8
- By:
- Publication type:
- Article
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 1, p. 57, doi. 10.1007/s10549-015-3423-2
- By:
- Publication type:
- Article
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).
- Published in:
- 2018
- By:
- Publication type:
- journal article